Institutional investors purchased a net $74.1 thousand shares of IDIX during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 72.83% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
| Other institutional | 45.36% |
| Individual stakeholders | 35.51% |
| Mutual fund holders | 27.47% |